Rinaldi-Carmona M - Search Results

1

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G. Rinaldi-Carmona M, et al. Life Sci. 1995;56(23-24):1941-7. doi: 10.1016/0024-3205(95)00174-5. Life Sci. 1995. PMID: 7776817

2

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.

Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrié P, Le Fur G. Rinaldi-Carmona M, et al. J Pharmacol Exp Ther. 2004 Sep;310(3):905-14. doi: 10.1124/jpet.104.067884. Epub 2004 May 6. J Pharmacol Exp Ther. 2004. PMID: 15131245

3

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

Rinaldi-Carmona M, Congy C, Santucci V, Simiand J, Gautret B, Neliat G, Labeeuw B, Le Fur G, Soubrie P, Breliere JC. Rinaldi-Carmona M, et al. J Pharmacol Exp Ther. 1992 Aug;262(2):759-68. J Pharmacol Exp Ther. 1992. PMID: 1501121

4

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.

Gueudet C, Santucci V, Rinaldi-Carmona M, Soubrié P, Le Fur G. Gueudet C, et al. Neuroreport. 1995 Jul 10;6(10):1421-5. doi: 10.1097/00001756-199507100-00015. Neuroreport. 1995. PMID: 7488739

5

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice.

Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrié P. Souilhac J, et al. Pharmacol Biochem Behav. 1995 May;51(1):3-7. doi: 10.1016/0091-3057(94)00396-z. Pharmacol Biochem Behav. 1995. PMID: 7617730

6

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, et al. Rinaldi-Carmona M, et al. FEBS Lett. 1994 Aug 22;350(2-3):240-4. doi: 10.1016/0014-5793(94)00773-x. FEBS Lett. 1994. PMID: 8070571 Free article.

7

Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.

Rinaldi-Carmona M, Congy C, Pointeau P, Vidal H, Brelière JC, Le Fur G. Rinaldi-Carmona M, et al. Life Sci. 1994;54(2):119-27. doi: 10.1016/0024-3205(94)00782-9. Life Sci. 1994. PMID: 8277817

8

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.

Rinaldi-Carmona M, Bouaboula M, Congy C, Oury-Donat F, Simiand J, Shire D, Casellas P, Soubrié P, Brelière JC, Le Fur G. Rinaldi-Carmona M, et al. Eur J Pharmacol. 1993 Jun 15;246(1):73-80. doi: 10.1016/0922-4106(93)90012-x. Eur J Pharmacol. 1993. PMID: 8354344

9

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.

Rinaldi-Carmona M, Congy C, Simiand J, Oury-Donat F, Soubrie P, Breliere JC, Le Fur G. Rinaldi-Carmona M, et al. Mol Pharmacol. 1993 Jan;43(1):84-9. Mol Pharmacol. 1993. PMID: 8423772

10

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.

Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, Brelière JC, Soubrié P, Le Fur G. Rinaldi-Carmona M, et al. Life Sci. 1996;58(15):1239-47. doi: 10.1016/0024-3205(96)00085-9. Life Sci. 1996. PMID: 8614277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters